PL3066074T3 - Związki pośrednie i sposoby syntezy pochodnych kalicheamycyny - Google Patents

Związki pośrednie i sposoby syntezy pochodnych kalicheamycyny

Info

Publication number
PL3066074T3
PL3066074T3 PL14802502T PL14802502T PL3066074T3 PL 3066074 T3 PL3066074 T3 PL 3066074T3 PL 14802502 T PL14802502 T PL 14802502T PL 14802502 T PL14802502 T PL 14802502T PL 3066074 T3 PL3066074 T3 PL 3066074T3
Authority
PL
Poland
Prior art keywords
intermediates
methods
calicheamicin derivatives
synthesizing
synthesizing calicheamicin
Prior art date
Application number
PL14802502T
Other languages
English (en)
Inventor
Robert Wayne Dugger
Leo Joseph LETENDRE
Vimalkumar Babubhai PATEL
Amarnauth Shastrie Prashad
Chunchun Zhang
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of PL3066074T3 publication Critical patent/PL3066074T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/02Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
    • C07C319/06Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols from sulfides, hydropolysulfides or polysulfides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/26Separation; Purification; Stabilisation; Use of additives
    • C07C319/28Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/46Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms
    • C07C323/48Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26Acyclic or carbocyclic radicals, substituted by hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A61K47/6809Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/06Separation; Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyrrole Compounds (AREA)
PL14802502T 2013-11-04 2014-10-28 Związki pośrednie i sposoby syntezy pochodnych kalicheamycyny PL3066074T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361899682P 2013-11-04 2013-11-04
EP14802502.6A EP3066074B1 (en) 2013-11-04 2014-10-28 Intermediates and methods for synthesizing calicheamicin derivatives
PCT/IB2014/065657 WO2015063680A1 (en) 2013-11-04 2014-10-28 Intermediates and methods for synthesizing calicheamicin derivatives

Publications (1)

Publication Number Publication Date
PL3066074T3 true PL3066074T3 (pl) 2020-05-18

Family

ID=51947406

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14802502T PL3066074T3 (pl) 2013-11-04 2014-10-28 Związki pośrednie i sposoby syntezy pochodnych kalicheamycyny

Country Status (17)

Country Link
US (2) US9902691B2 (pl)
EP (1) EP3066074B1 (pl)
JP (4) JP6494240B2 (pl)
KR (1) KR101932824B1 (pl)
CN (2) CN105683159B (pl)
AU (1) AU2014343268B2 (pl)
CA (3) CA2929283C (pl)
DK (1) DK3066074T3 (pl)
ES (1) ES2768611T3 (pl)
HU (1) HUE047665T2 (pl)
IL (1) IL244985B (pl)
MX (2) MX391523B (pl)
PL (1) PL3066074T3 (pl)
PT (1) PT3066074T (pl)
RU (1) RU2640197C1 (pl)
SI (1) SI3066074T1 (pl)
WO (1) WO2015063680A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101630890B1 (ko) 2008-09-10 2016-06-15 콤랩스. 인크. 광역 위치 결정 시스템
US9902691B2 (en) * 2013-11-04 2018-02-27 Pfizer Inc. Intermediates and methods for synthesizing calicheamicin derivatives

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US577070A (en) 1897-02-16 Machines
US4970198A (en) * 1985-10-17 1990-11-13 American Cyanamid Company Antitumor antibiotics (LL-E33288 complex)
US5053394A (en) 1988-09-21 1991-10-01 American Cyanamid Company Targeted forms of methyltrithio antitumor agents
ATE112172T1 (de) * 1987-10-30 1994-10-15 American Cyanamid Co Targetformer von antitumor-methyltrithioagenzien.
US5770701A (en) 1987-10-30 1998-06-23 American Cyanamid Company Process for preparing targeted forms of methyltrithio antitumor agents
IL115770A (en) * 1989-04-14 1999-03-12 American Cyanamid Co Substituted disulfides of formula q-sp-ss-w their preparation and use for inhibiting the growth of tumours and for treating bacterial infections
US5773001A (en) * 1994-06-03 1998-06-30 American Cyanamid Company Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
PL224001B1 (pl) * 2002-05-02 2016-11-30 Wyeth Corp Sposób wytwarzania stabilnej liofilizowanej kompozycji obejmującej monomeryczne koniugaty pochodna kalicheamycyny/przeciwciało anty-CD22, kompozycja otrzymana tym sposobem oraz jej zastosowanie
WO2007014054A2 (en) * 2005-07-22 2007-02-01 Glaxo Group Limted Benzenesulfonamide inhibitor of ccr2 chemokine receptor
US8142287B2 (en) 2005-10-11 2012-03-27 Zeemote Technology Inc. Universal controller for toys and games
JP2007210974A (ja) * 2006-02-13 2007-08-23 Sankyo Co Ltd 置換されたウレア化合物を含有する医薬
TW200806685A (en) * 2006-02-21 2008-02-01 Wyeth Corp Processes for the convergent synthesis of calicheamicin derivatives
US20090298811A1 (en) * 2006-09-12 2009-12-03 Pfizer Inc Benzimidazolone derivatives
BRPI0811140B1 (pt) * 2007-05-22 2022-08-16 Wyeth Llc Processos melhorados para produção de hidrazidas
AR098221A1 (es) * 2013-11-04 2016-05-18 Pfizer Conjugados de anticuerpo anti-efna4-fármaco
US9902691B2 (en) * 2013-11-04 2018-02-27 Pfizer Inc. Intermediates and methods for synthesizing calicheamicin derivatives

Also Published As

Publication number Publication date
US9902691B2 (en) 2018-02-27
US20180134656A1 (en) 2018-05-17
CA2929283A1 (en) 2015-05-07
CN105683159A (zh) 2016-06-15
EP3066074A1 (en) 2016-09-14
DK3066074T3 (da) 2020-02-10
US10508081B2 (en) 2019-12-17
AU2014343268A1 (en) 2016-05-05
US20160251389A1 (en) 2016-09-01
SI3066074T1 (sl) 2020-03-31
JP6854839B2 (ja) 2021-04-07
AU2014343268B2 (en) 2018-11-15
HUE047665T2 (hu) 2020-05-28
KR20160065944A (ko) 2016-06-09
RU2640197C1 (ru) 2017-12-27
HK1219721A1 (zh) 2017-04-13
ES2768611T3 (es) 2020-06-23
KR101932824B1 (ko) 2018-12-27
CA3131631A1 (en) 2015-05-07
JP2021107393A (ja) 2021-07-29
JP6494240B2 (ja) 2019-04-03
WO2015063680A1 (en) 2015-05-07
HK1250718A1 (zh) 2019-01-11
MX2016005511A (es) 2016-07-22
MX391523B (es) 2025-03-21
IL244985A0 (en) 2016-05-31
CN108047287B (zh) 2021-04-27
JP2019089847A (ja) 2019-06-13
JP2015107963A (ja) 2015-06-11
EP3066074B1 (en) 2019-12-11
CN105683159B (zh) 2017-12-19
MX371011B (es) 2020-01-13
JP2022183287A (ja) 2022-12-08
CN108047287A (zh) 2018-05-18
CA3191168A1 (en) 2015-05-07
JP7163439B2 (ja) 2022-10-31
IL244985B (en) 2019-06-30
CA2929283C (en) 2022-07-19
PT3066074T (pt) 2020-02-03

Similar Documents

Publication Publication Date Title
ZA201601737B (en) Processes for preparing dihydropyrimidine derivatives and intermediates thereof
HUE036581T2 (hu) Anti-FCRH5 antitestek
GB201322583D0 (en) Antibodies
GB201315487D0 (en) Antibodies
GB201315378D0 (en) Speaker apparatus
GB201303913D0 (en) Synthesis apparatus and method
GB201308658D0 (en) Antibodies
GB201315486D0 (en) Antibodies
GB201315777D0 (en) Novel method
GB2530447B (en) Urea synthesis method
BR112016002104A2 (pt) método de síntese de 3-oxopent-4-enoil-coa
EP3041621A4 (en) Metal forming apparatus
PL2821393T3 (pl) Sposób syntezy związków azowych
GB201310151D0 (en) Novel method
ZA201601775B (en) Method for the synthesis of irinotecan
PT2799426T (pt) Novo processo para a síntese de aminaftona
IL244985A0 (en) Intermediates and methods for the preparation of calicheamicin derivatives
SI2757513T1 (sl) Postopek obračunavanja uporabe lokacij
SG11201602693QA (en) Methods and intermediates for preparing macrolactams
PL2878426T3 (pl) Urządzenie formujące
IL241475A0 (en) method for synthesis
EP2947075B8 (en) Synthesis method of thiadiazolylamide derivative
PL2873503T3 (pl) Urządzenie formujące
SG10201701021XA (en) Method of synthesis
HUP1300722A2 (en) Norsteroid intermediates and process for their preparation